Al Sandrock

Biogen, Morrisville, NC, United States 
"Al Sandrock"
Mean distance: 16.23 (cluster 11)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bloomgren G, Richman S, Hotermans C, et al. (2012) Risk of natalizumab-associated progressive multifocal leukoencephalopathy. The New England Journal of Medicine. 366: 1870-80
Sandrock AW, Rudick RA. (2012) Multiple sclerosis Translational Neuroscience: Applications in Psychiatry, Neurology, and Neurodevelopmental Disorders. 178-196
Wang YC, Sandrock A, Richert JR, et al. (2011) Short-Term Relapse Quantitation as a Fully Surrogate Endpoint for Long-Term Sustained Progression of Disability in RRMS Patients Treated with Natalizumab. Neurology Research International. 2011: 195831
Bozic C, Richman S, Plavina T, et al. (2011) Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1. Annals of Neurology. 70: 742-50
Rudick RA, Kappos L, Kinkel R, et al. (2011) Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 353-60
Rudick RA, O'Connor PW, Polman CH, et al. (2010) Assessment of JC virus DNA in blood and urine from natalizumab-treated patients. Annals of Neurology. 68: 304-10
Gorelik L, Lerner M, Bixler S, et al. (2010) Anti-JC virus antibodies: implications for PML risk stratification. Annals of Neurology. 68: 295-303
Radue EW, Stuart WH, Calabresi PA, et al. (2010) Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis. Journal of the Neurological Sciences. 292: 28-35
Bozic C, LaGuette J, Sandrock A. (2010) Reply: To PMID 19798640. Annals of Neurology. 67: 271-2
Hughes RA, Gorson KC, Cros D, et al. (2010) Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology. 74: 651-7
See more...